PTC Therapeutics, Inc.
$65.65
-$0.83 (-1.25%)
$65.06Day Range$66.54
Key Statistics
Market Cap
$5.48B
Shares Outstanding
83.5M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Jun 20, 2013
Round Lot
100
Locale
US
Trading Data
Day Open
$66.51
Day High
$66.54
Day Low
$65.06
Volume
1.03M
VWAP
$65.61
Prev Close
$66.48
Transactions
--
Acc. Volume
--
About PTC Therapeutics, Inc.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.
PHARMACEUTICAL PREPARATIONSSIC 2834991 employees500 WARREN CORPORATE CENTER DRIVE, WARREN, NJ, 07059(908) 222-7000IPO Jun 20, 2013US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001070081
- Composite FIGI
- BBG000QT15P7
- Share Class FIGI
- BBG001SNNC86
- Ticker Root
- PTCT
- SIC Code
- 2834
About PTC Therapeutics, Inc. (PTCT) Stock
PTC Therapeutics, Inc. (PTCT) closed the 2026-09-15 session at $65.65, down 1.25% versus the previous close (-0.83). The stock opened at $66.51 and traded between $65.06 and $66.54 during that session. Session trading volume was 1.0M shares. The volume-weighted average price (VWAP) is $65.61.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.
PTC Therapeutics, Inc. has a market capitalization of $5.48 billion. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. PTCT is listed on the XNAS exchange. The company employs approximately 991 people. PTC Therapeutics, Inc. is headquartered in WARREN, NJ. The recorded listing date is 2013-06-20.
On this page you can find market PTCT stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.